Eriko Nakamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eriko Nakamura has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Atsushi Yamashita
Department of Pathology, Faculty of Medicine University of Miyazaki Miyazaki Japan
6 shared publications Sayaka Moriguchi-Goto
Department of Diagnostic Pathology, University of Miyazaki Hospital, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
5 shared publications- Toshihiro Gi
Department of Pathology, Faculty of Medicine, University of Miyazaki
5 shared publications - Nobuyuki Oguri
Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
4 shared publications Yujiro Asada
Department of Pathology, Miyazaki Medical Association Hospital
4 shared publicationsKazunari Maekawa
University of Miyazaki
3 shared publications
Latest Publications
- 21 July 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (9)
Malignant syphilis with presumed multifocal osteomyelitis in a patient with human immunodeficiency virus: A case report
- 21 July 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (9)
Malignant syphilis with presumed multifocal osteomyelitis in a patient with human immunodeficiency virus: A case report
- Open Access
- 26 March 2026
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 10 (3) , 103433
Cathepsin G is associated with cerebral vascular injury in myeloid leukemia: a pathologic insight into intracranial hemorrhage
- 26 March 2026
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 10 (3) , 103433
Open AccessCathepsin G is associated with cerebral vascular injury in myeloid leukemia: a pathologic insight into intracranial hemorrhage
- Open Access
Protease-activated receptor-1 expression in cytotrophoblasts and platelet-fibrin thrombus formation increase in placenta accreta spectrum
Background: Placenta accreta spectrum (PAS) is characterized by abnormal trophoblastic invasion into the uterine myometrium and is a cause of postpartum hemorrhage and maternal death. Protease-activated receptor-1 (PAR-1) promotes various cellular actions, including invasion. Here, we analyzed the expression of PAR-1, platelet antigen, and fibrin in PAS. Methods: We analyzed 49 PAS cases (placenta accreta vera [accreta vera], 31 cases; placenta increta [increta], 8 cases; placenta percreta [percreta], 10 cases, classified by the degree of placental villous invasion) and 33 control cases. We immunohistochemically examined the expression of PAR-1, platelet glycoprotein (GP) IIb/IIIa, and fibrin. Results: The frequency of previous cesarean section was higher in the increta and percreta groups than in the control and accreta vera groups. PAR-1 expression in placental villi was weak and limited in extent in control cases, whereas immunoreactivity and staining density increased in increta and percreta. Immunofluorescence revealed PAR-1 expression in cytotrophoblasts of placental villi and in aggregated platelets. PAR-1 expression scores in cytotrophoblasts increased significantly with the degree of villous invasion (accreta vera, increta, percreta) compared with controls. The immunopositive areas for GPIIb/IIIa and fibrin were significantly larger in PAS groups than in controls. Furthermore, the immunopositive areas for platelets and fibrin were positively correlated with the PAR-1 expression score. Conclusion: These results indicate that PAR-1 may play a role in placental villous invasion and that a thrombogenic placental environment may influence PAR-1 activation.
Open AccessProtease-activated receptor-1 expression in cytotrophoblasts and platelet-fibrin thrombus formation increase in placenta accreta spectrum
Background: Placenta accreta spectrum (PAS) is characterized by abnormal trophoblastic invasion into the uterine myometrium and is a cause of postpartum hemorrhage and maternal death. Protease-activated receptor-1 (PAR-1) promotes various cellular actions, including invasion. Here, we analyzed the expression of PAR-1, platelet antigen, and fibrin in PAS. Methods: We analyzed 49 PAS cases (placenta accreta vera [accreta vera], 31 cases; placenta increta [increta], 8 cases; placenta percreta [percreta], 10 cases, classified by the degree of placental villous invasion) and 33 control cases. We immunohistochemically examined the expression of PAR-1, platelet glycoprotein (GP) IIb/IIIa, and fibrin. Results: The frequency of previous cesarean section was higher in the increta and percreta groups than in the control and accreta vera groups. PAR-1 expression in placental villi was weak and limited in extent in control cases, whereas immunoreactivity and staining density increased in increta and percreta. Immunofluorescence revealed PAR-1 expression in cytotrophoblasts of placental villi and in aggregated platelets. PAR-1 expression scores in cytotrophoblasts increased significantly with the degree of villous invasion (accreta vera, increta, percreta) compared with controls. The immunopositive areas for GPIIb/IIIa and fibrin were significantly larger in PAS groups than in controls. Furthermore, the immunopositive areas for platelets and fibrin were positively correlated with the PAR-1 expression score. Conclusion: These results indicate that PAR-1 may play a role in placental villous invasion and that a thrombogenic placental environment may influence PAR-1 activation.
- Open Access
Cathepsin G is associated with cerebral vascular injury in leukemia: A pathological insight into intracranial hemorrhage
Intracranial hemorrhage (ICH) is a fatal complication of leukemia; however, the mechanisms underlying its development, particularly central nervous system (CNS) involvement and vascular injury, remain unclear. This autopsy-based study investigated the histopathological features of cerebral vessels in leukemia and the expression of hemostasis-related factors in leukemia cells. Thirty-eight leukemia cases and 20 matched controls were included. A histopathological analysis of CNS tissues was performed to evaluate ICH, leukemia cell localization, and vascular injury. Immunohistochemistry was conducted to assess the expression of vascular endothelial growth factor (VEGF), cathepsin G, tissue-plasminogen activator, urokinase-plasminogen activator, urokinase plasminogen activator receptor, and tissue factor in leukemia cells. Vascular integrity and permeability were evaluated using stains for smooth muscle actin, collagen, fibrin, and von Willebrand factor. ICH was identified in 66% of leukemia cases and was associated with fatal brain herniation in 40%. CNS involvement was observed in 59% of cases, often without a clinical diagnosis. The leukemia cell infiltration of meninges and vascular walls was frequently associated with changes in smooth muscle cells and adventitial collagen. CNS vascular injury was frequently associated with ICH in the presence of leukemia cell infiltration. VEGF and urokinase-plasminogen activator were highly expressed in leukemia cells. VEGF was associated with meningeal invasion, while cathepsin G was predominantly expressed in myeloid leukemia and linked to vascular damage. These results suggest that the leukemia cell infiltration of cerebral vascular walls plays an important role in cerebral vessel injury and leukemia cell-related ICH via VEGF and cathepsin G expression. Key points: Leukemia cell infiltration into cerebral vascular walls is associated with vascular damage and intracranial hemorrhage in autopsy cases. The expression of VEGF and cathepsin G in leukemia may serve as markers of CNS involvement and cerebral vascular injury, respectively.
Open AccessCathepsin G is associated with cerebral vascular injury in leukemia: A pathological insight into intracranial hemorrhage
Intracranial hemorrhage (ICH) is a fatal complication of leukemia; however, the mechanisms underlying its development, particularly central nervous system (CNS) involvement and vascular injury, remain unclear. This autopsy-based study investigated the histopathological features of cerebral vessels in leukemia and the expression of hemostasis-related factors in leukemia cells. Thirty-eight leukemia cases and 20 matched controls were included. A histopathological analysis of CNS tissues was performed to evaluate ICH, leukemia cell localization, and vascular injury. Immunohistochemistry was conducted to assess the expression of vascular endothelial growth factor (VEGF), cathepsin G, tissue-plasminogen activator, urokinase-plasminogen activator, urokinase plasminogen activator receptor, and tissue factor in leukemia cells. Vascular integrity and permeability were evaluated using stains for smooth muscle actin, collagen, fibrin, and von Willebrand factor. ICH was identified in 66% of leukemia cases and was associated with fatal brain herniation in 40%. CNS involvement was observed in 59% of cases, often without a clinical diagnosis. The leukemia cell infiltration of meninges and vascular walls was frequently associated with changes in smooth muscle cells and adventitial collagen. CNS vascular injury was frequently associated with ICH in the presence of leukemia cell infiltration. VEGF and urokinase-plasminogen activator were highly expressed in leukemia cells. VEGF was associated with meningeal invasion, while cathepsin G was predominantly expressed in myeloid leukemia and linked to vascular damage. These results suggest that the leukemia cell infiltration of cerebral vascular walls plays an important role in cerebral vessel injury and leukemia cell-related ICH via VEGF and cathepsin G expression. Key points: Leukemia cell infiltration into cerebral vascular walls is associated with vascular damage and intracranial hemorrhage in autopsy cases. The expression of VEGF and cathepsin G in leukemia may serve as markers of CNS involvement and cerebral vascular injury, respectively.
- Open Access
- 4 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0316474
Inflammatory stimuli and hypoxia on atherosclerotic plaque thrombogenicity: Linking macrophage tissue factor and glycolysis
Background: The thrombogenic potential of cells within atherosclerotic plaques is critical in the formation of a coronary thrombus. We hypothesized that a combination of inflammatory and hypoxic stimuli enhances tissue factor (TF) expression and glycolysis in cells in atherosclerotic plaques and contributes to coronary thrombus formation. Aims: To identify TF- and hexokinase (HK)-II-expressing cells in coronary atherosclerotic plaques and thrombi and determine the effects of combined inflammatory and hypoxic stimuli and glycolysis on TF expression in peripheral blood mononuclear cell-derived macrophages. Methods: We immunohistochemically assessed TF and HK-II expression in stable (n = 20) and unstable (n = 24) human coronary plaques and aspirated acute coronary thrombi (n = 15). The macrophages were stimulated with tumor necrosis factor-α, interferon-γ, or interleukin-10 under normoxic (21% O2) or hypoxic (1% O2) conditions, and TF expression was assessed. Results: TF and HK-II expression were increased in unstable plaques compared with stable plaques. The number of CD68- and HK-II-immunopositive cells positively correlated with the number of TF-immunopositive cells. TF- and HK-II-expressing macrophages, which expressed M1- or M2-like markers, were involved in platelet-fibrin thrombus formation in ruptured plaques. The combination of inflammatory and hypoxic conditions additively augmented TF expression and procoagulant activity in the cultured macrophages. Inhibition of glycolysis with 2-deoxyglucose reduced the augmented TF expression and procoagulant activity. Conclusion: Combined inflammatory and hypoxic conditions in atherosclerotic plaques may markedly enhance procoagulant activity in macrophages and contribute to coronary thrombus formation following plaque disruption. Macrophage TF expression may be associated with glycolysis.
- 4 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0316474
Open AccessInflammatory stimuli and hypoxia on atherosclerotic plaque thrombogenicity: Linking macrophage tissue factor and glycolysis
Background: The thrombogenic potential of cells within atherosclerotic plaques is critical in the formation of a coronary thrombus. We hypothesized that a combination of inflammatory and hypoxic stimuli enhances tissue factor (TF) expression and glycolysis in cells in atherosclerotic plaques and contributes to coronary thrombus formation. Aims: To identify TF- and hexokinase (HK)-II-expressing cells in coronary atherosclerotic plaques and thrombi and determine the effects of combined inflammatory and hypoxic stimuli and glycolysis on TF expression in peripheral blood mononuclear cell-derived macrophages. Methods: We immunohistochemically assessed TF and HK-II expression in stable (n = 20) and unstable (n = 24) human coronary plaques and aspirated acute coronary thrombi (n = 15). The macrophages were stimulated with tumor necrosis factor-α, interferon-γ, or interleukin-10 under normoxic (21% O2) or hypoxic (1% O2) conditions, and TF expression was assessed. Results: TF and HK-II expression were increased in unstable plaques compared with stable plaques. The number of CD68- and HK-II-immunopositive cells positively correlated with the number of TF-immunopositive cells. TF- and HK-II-expressing macrophages, which expressed M1- or M2-like markers, were involved in platelet-fibrin thrombus formation in ruptured plaques. The combination of inflammatory and hypoxic conditions additively augmented TF expression and procoagulant activity in the cultured macrophages. Inhibition of glycolysis with 2-deoxyglucose reduced the augmented TF expression and procoagulant activity. Conclusion: Combined inflammatory and hypoxic conditions in atherosclerotic plaques may markedly enhance procoagulant activity in macrophages and contribute to coronary thrombus formation following plaque disruption. Macrophage TF expression may be associated with glycolysis.
- Open Access
Neutrophil extracellular traps and thrombotic components across human coronary plaque progression: Association of intraplaque hemorrhage with NET formation
Neutrophil extracellular traps (NETs), fibrin, and von Willebrand factor (VWF) are present in acute coronary thrombotic plaques. This study aimed to investigate their distribution among the coronary atherosclerotic progression and the potential association between intraplaque hemorrhage and NET formation. Coronary artery sections from autopsy cases of non-cardiac death (n = 5, 37 sections) and ischemic heart disease (n = 11, 65 sections) were classified into six morphological groups and examined immunohistochemically. Effects of intraplaque hemorrhage related molecules on NETs formation were examined with human peripheral blood derived neutrophils. Neutrophils and citrullinated histone H3 (CitH3), a marker of NETs, were rarely observed except in thin-cap fibroatheromas and ruptured plaques. Fibrin deposition was detected from pathological intimal thickening onward and increased in thin-cap fibroatheromas and ruptured plaques. VWF deposition was mainly observed in necrotic cores and was abundant in ruptured plaques. Among non-ruptured plaques, CitH3- and fibrin-positive areas were significantly larger in plaques with intraplaque hemorrhage than in those without hemorrhage. In cultured human neutrophils, stimulation with hemin, ATP, ADP, or thrombin induced NET formation. These findings suggest that neutrophils, NETs, and platelets are not prominent features of early human coronary atherosclerotic lesions but become more evident with plaque progression and destabilization. In contrast, fibrin and VWF deposition can already be detected in earlier lesions. Intraplaque hemorrhage may further promote fibrin deposition, and NET-associated responses via erythrocyte-, platelets, coagulation-related molecules. Neutrophil accumulation and VWF deposition may predominantly accompany plaque rupture.
Open AccessNeutrophil extracellular traps and thrombotic components across human coronary plaque progression: Association of intraplaque hemorrhage with NET formation
Neutrophil extracellular traps (NETs), fibrin, and von Willebrand factor (VWF) are present in acute coronary thrombotic plaques. This study aimed to investigate their distribution among the coronary atherosclerotic progression and the potential association between intraplaque hemorrhage and NET formation. Coronary artery sections from autopsy cases of non-cardiac death (n = 5, 37 sections) and ischemic heart disease (n = 11, 65 sections) were classified into six morphological groups and examined immunohistochemically. Effects of intraplaque hemorrhage related molecules on NETs formation were examined with human peripheral blood derived neutrophils. Neutrophils and citrullinated histone H3 (CitH3), a marker of NETs, were rarely observed except in thin-cap fibroatheromas and ruptured plaques. Fibrin deposition was detected from pathological intimal thickening onward and increased in thin-cap fibroatheromas and ruptured plaques. VWF deposition was mainly observed in necrotic cores and was abundant in ruptured plaques. Among non-ruptured plaques, CitH3- and fibrin-positive areas were significantly larger in plaques with intraplaque hemorrhage than in those without hemorrhage. In cultured human neutrophils, stimulation with hemin, ATP, ADP, or thrombin induced NET formation. These findings suggest that neutrophils, NETs, and platelets are not prominent features of early human coronary atherosclerotic lesions but become more evident with plaque progression and destabilization. In contrast, fibrin and VWF deposition can already be detected in earlier lesions. Intraplaque hemorrhage may further promote fibrin deposition, and NET-associated responses via erythrocyte-, platelets, coagulation-related molecules. Neutrophil accumulation and VWF deposition may predominantly accompany plaque rupture.
- Open Access
- 17 February 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (2) , e0281730
Altered choline level in atherosclerotic lesions: Upregulation of choline transporter-like protein 1 in human coronary unstable plaque
Inflammatory activity and hypoxia in atherosclerotic plaques are associated with plaque instability and thrombotic complications. Recent studies show that vascular cell metabolism affects atherogenesis and thrombogenicity. This study aimed to identify the metabolites in macrophage-rich unstable plaques that modulate atherogenesis and serve as potential markers of plaque instability. Atherosclerotic plaques were induced by balloon injury in the iliofemoral arteries of rabbits fed on a conventional or 0.5% cholesterol diet. At 3 months post-balloon injury, the arteries and cardiac tissues were subjected to histological, quantitative real-time polymerase chain reaction, and metabolomic analyses. The identified metabolite-related proteins were immunohistochemically analyzed in stable and unstable plaques from human coronary arteries. The factors modulating the identified metabolites were examined in macrophages derived from human peripheral blood mononuclear cells. Metabolomic analysis revealed that choline and guanine levels in macrophage-rich arteries were upregulated compared with those in non-injured arteries and cardiac tissues. Vascular choline levels, but not guanine levels, were positively correlated with the areas immunopositive for macrophages and tumor necrosis factor (TNF)-α and matrix metalloproteinase (MMP) 9 mRNA levels in injured arteries. In human coronary arteries, choline transporter-like protein (CTL) 1 was mainly localized to macrophages within plaques. The area that was immunopositive for CTL1 in unstable plaques was significantly higher than that in stable plaques. Intracellular choline levels were upregulated upon stimulation with TNF-α but were downregulated under hypoxia in cultured macrophages. Administration of choline upregulated the expression of TNF-α and CTL1 mRNA in cultured macrophages. The transfection of CTL1 small interfering RNA decreased CTL1, TNF-α, and MMP9 mRNA levels in cultured macrophages. These results suggest that choline metabolism is altered in macrophage-rich atherosclerotic lesions and unstable plaques. Thus, CTL1 may be potential markers of plaque instability.
- 17 February 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (2) , e0281730
Open AccessAltered choline level in atherosclerotic lesions: Upregulation of choline transporter-like protein 1 in human coronary unstable plaque
Inflammatory activity and hypoxia in atherosclerotic plaques are associated with plaque instability and thrombotic complications. Recent studies show that vascular cell metabolism affects atherogenesis and thrombogenicity. This study aimed to identify the metabolites in macrophage-rich unstable plaques that modulate atherogenesis and serve as potential markers of plaque instability. Atherosclerotic plaques were induced by balloon injury in the iliofemoral arteries of rabbits fed on a conventional or 0.5% cholesterol diet. At 3 months post-balloon injury, the arteries and cardiac tissues were subjected to histological, quantitative real-time polymerase chain reaction, and metabolomic analyses. The identified metabolite-related proteins were immunohistochemically analyzed in stable and unstable plaques from human coronary arteries. The factors modulating the identified metabolites were examined in macrophages derived from human peripheral blood mononuclear cells. Metabolomic analysis revealed that choline and guanine levels in macrophage-rich arteries were upregulated compared with those in non-injured arteries and cardiac tissues. Vascular choline levels, but not guanine levels, were positively correlated with the areas immunopositive for macrophages and tumor necrosis factor (TNF)-α and matrix metalloproteinase (MMP) 9 mRNA levels in injured arteries. In human coronary arteries, choline transporter-like protein (CTL) 1 was mainly localized to macrophages within plaques. The area that was immunopositive for CTL1 in unstable plaques was significantly higher than that in stable plaques. Intracellular choline levels were upregulated upon stimulation with TNF-α but were downregulated under hypoxia in cultured macrophages. Administration of choline upregulated the expression of TNF-α and CTL1 mRNA in cultured macrophages. The transfection of CTL1 small interfering RNA decreased CTL1, TNF-α, and MMP9 mRNA levels in cultured macrophages. These results suggest that choline metabolism is altered in macrophage-rich atherosclerotic lesions and unstable plaques. Thus, CTL1 may be potential markers of plaque instability.
- Open Access
- 1 October 2020
- Published by The Japanese Journal of Gastroenterological Surgery in The Japanese Journal of Gastroenterological Surgery
- Vol. 53 (10) , 817-825
A Case of Rectal Carcinoma with Synchronous Neuroendocrine Differentiated Prostate Carcinoma That Spread to the Mesorectal Lymph Node
症例は75歳の男性で,排尿障害,前立腺特異抗原(prostate specific antigen;以下,PSAと略記)高値にて針生検を施行したところ前立腺癌と診断され,精査中に下部直腸(Rb)前壁に1/3周性Type 2病変を認めた.骨盤MRIで前立腺癌は肛門管直上で直腸壁に接しており,直腸癌とも近接していた.直腸間膜リンパ節(mesorectal lymph node;以下,MLNと略記),側方および鼠径部に多数のリンパ節腫大,および複数の骨転移を認めた.前立腺癌(Stage D)に対しホルモン療法を1サイクル施行後,PSA値の低下,側方リンパ節の縮小を確認し,腹腔鏡下腹会陰式直腸切断術を施行した.直腸癌はtub1,pT2,pN0,pStage Iで,MLN転移は神経内分泌分化を伴う前立腺癌の転移であった.前立腺癌のMLN転移の報告はごくまれであるが,本症例のように浸潤傾向の強い前立腺癌において,直腸間膜内へのリンパ行性転移を来しうることを念頭に置くべきと思われた.
- 1 October 2020
- Published by The Japanese Journal of Gastroenterological Surgery in The Japanese Journal of Gastroenterological Surgery
- Vol. 53 (10) , 817-825
Open AccessA Case of Rectal Carcinoma with Synchronous Neuroendocrine Differentiated Prostate Carcinoma That Spread to the Mesorectal Lymph Node
症例は75歳の男性で,排尿障害,前立腺特異抗原(prostate specific antigen;以下,PSAと略記)高値にて針生検を施行したところ前立腺癌と診断され,精査中に下部直腸(Rb)前壁に1/3周性Type 2病変を認めた.骨盤MRIで前立腺癌は肛門管直上で直腸壁に接しており,直腸癌とも近接していた.直腸間膜リンパ節(mesorectal lymph node;以下,MLNと略記),側方および鼠径部に多数のリンパ節腫大,および複数の骨転移を認めた.前立腺癌(Stage D)に対しホルモン療法を1サイクル施行後,PSA値の低下,側方リンパ節の縮小を確認し,腹腔鏡下腹会陰式直腸切断術を施行した.直腸癌はtub1,pT2,pN0,pStage Iで,MLN転移は神経内分泌分化を伴う前立腺癌の転移であった.前立腺癌のMLN転移の報告はごくまれであるが,本症例のように浸潤傾向の強い前立腺癌において,直腸間膜内へのリンパ行性転移を来しうることを念頭に置くべきと思われた.